Ellington Credit Company Reports Preliminary Fourth Quarter 2024 Results and Provides Conversion Update

Stock Information for Nektar Therapeutics

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nektar Therapeutics

Ellington Credit Declares Monthly Common Dividend
Ellington Credit to Ring the Closing Bell at the New York Stock Exchange
Ellington Credit Completes Conversion to Closed-end Fund
Ellington Credit Confirms April 1 Conversion Date
Ellington Credit Company Reports Fourth Quarter 2024 Results
Ellington Credit Declares Monthly Common Dividend
Ellington Credit Company Announces Release Date of Fourth Quarter 2024 Earnings, Conference Call, and Investor Presentation
Ellington Credit Declares Monthly Common Dividend

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.